Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area: What's new 12 months later?
Open Access
- 17 July 2023
- journal article
- research article
- Published by Elsevier in Annals of Hepatology
- Vol. 28 (6) , 101141
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Delivery of hepato-pancreato-biliary surgery during the COVID-19 pandemic: an European-African Hepato-Pancreato-Biliary Association (E-AHPBA) cross-sectional surveyHPB, 2020
- Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemicAnnals of Oncology, 2020
- COVID-19 epidemic: Proposed alternatives in the management of digestive cancers: A French intergroup clinical point of view (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR)Digestive and Liver Disease, 2020
- Suggestions for the care of patients with liver disease during the Coronavirus 2019 pandemicClinics and Research in Hepatology and Gastroenterology, 2020
- Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paperJHEP Reports, 2020
- Strategy for the practice of digestive and oncological surgery during the Covid-19 epidemicJournal of Visceral Surgery, 2020
- How to transform a general hospital into an “infectious disease hospital” during the epidemic of COVID-19Critical Care, 2020
- Critical care response to a hospital outbreak of the 2019-nCoV infection in Shenzhen, ChinaCritical Care, 2020
- EASL Clinical Practice Guidelines: Management of hepatocellular carcinomaJournal of Hepatology, 2018
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesThe Lancet, 2007